bioMérieux: organic growth almost 10% over first 9m

(CercleFinance.com) - bioMérieux has posted turnover of 1.
749 billion euros for the first nine months of 2018, up 4.5% as reported and up 9.8% at constant exchange rates and consolidation scope.

The In vitro diagnostics specialist explains that its growth has been boosted by three major growth drivers; i.e. molecular biology with the BioFire range, growth in the Asia-Pacific region and finally industrial applications.

Alexandre Mérieux, Chairman and Chief Executive Officer, said: “bioMérieux delivered another robust sales performance in the third quarter of 2018, with organic growth nearing 9%. These positive dynamics place the Group on track to achieving its financial objectives for the year.”



Copyright (c) 2018 CercleFinance.com. All rights reserved.